Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer ; volume:19 ; number:1 ; day:5 ; month:5 ; year:2021 ; pages:1-10 ; date:12.2021
World journal of surgical oncology ; 19, Heft 1 (5.5.2021), 1-10, 12.2021
- Urheber
-
Lin, Huaqin
Wang, Lei
Zhong, Xiaohong
Zhang, Xueqing
Shao, Lingdong
Wu, Junxin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-021-02251-0
- URN
-
urn:nbn:de:101:1-2021090821182478597619
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lin, Huaqin
- Wang, Lei
- Zhong, Xiaohong
- Zhang, Xueqing
- Shao, Lingdong
- Wu, Junxin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
Computertomography-based prediction of complete response following neoadjuvant chemoradiotherapy of locally advanced rectal cancer
Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma
Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation
Total neoadjuvant therapy for each locally advanced rectal cancer?
Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity
The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
Computertomography-based prediction of complete response following neoadjuvant chemoradiotherapy of locally advanced rectal cancer
Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma
Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation
Total neoadjuvant therapy for each locally advanced rectal cancer?
Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity
The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
Computertomography-based prediction of complete response following neoadjuvant chemoradiotherapy of locally advanced rectal cancer
Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma
Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation
Total neoadjuvant therapy for each locally advanced rectal cancer?
Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity
The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer